BACKGROUND AND PURPOSE: Glutamate levels may be informative about the declining neuronal health in the central nervous system. We used an advanced proton MR spectroscopy (1 H-MRS) protocol composed of semi-localization by adiabatic selective refocusing (sLASER) localization and FAST(EST)MAP shimming for detection of alterations in brain glutamate concentrations in patients with amnestic mild cognitive impairment. METHODS: Participants with amnestic mild cognitive impairment (n = 14; median age = 80) and age- and sex-matched clinically normal controls (n = 32; median age = 79) from the population-based Mayo Clinic Study of Aging were recruited prospectively to the 3T single-voxel 1 H-MRS study that examined metabolite changes in the posterior cingulate gyri. To be included, controls had to have low β-amyloid load on [11 C] Pittsburgh Compound B (PiB)-PET (standard uptake value ratio; SUVr < 1.42) and patients with amnestic mild cognitive impairment had to have high β-amyloid load (SUVr ≥ 1.42). RESULTS: Glutamate concentration and the glutamate/myo-inositol ratio were lower in patients with amnestic mild cognitive impairment than clinically normal controls (P < .05). Higher global cortical PiB-PET SUVr correlated with lower glutamate/myo-inositol (r = -.3, P = .04). CONCLUSIONS: The advanced sLASER with FAST(EST)MAP shimming is a promising protocol for identifying glutamate alterations. Advanced 1 H-MRS protocols may add to the understanding of early Alzheimer's disease pathophysiology through detection of glutamate concentration in posterior cingulate gyri of individuals with amnestic mild cognitive impairment.
BACKGROUND AND PURPOSE:Glutamate levels may be informative about the declining neuronal health in the central nervous system. We used an advanced proton MR spectroscopy (1 H-MRS) protocol composed of semi-localization by adiabatic selective refocusing (sLASER) localization and FAST(EST)MAP shimming for detection of alterations in brain glutamate concentrations in patients with amnestic mild cognitive impairment. METHODS:Participants with amnestic mild cognitive impairment (n = 14; median age = 80) and age- and sex-matched clinically normal controls (n = 32; median age = 79) from the population-based Mayo Clinic Study of Aging were recruited prospectively to the 3T single-voxel 1 H-MRS study that examined metabolite changes in the posterior cingulate gyri. To be included, controls had to have low β-amyloid load on [11 C] Pittsburgh Compound B (PiB)-PET (standard uptake value ratio; SUVr < 1.42) and patients with amnestic mild cognitive impairment had to have high β-amyloid load (SUVr ≥ 1.42). RESULTS:Glutamate concentration and the glutamate/myo-inositol ratio were lower in patients with amnestic mild cognitive impairment than clinically normal controls (P < .05). Higher global cortical PiB-PET SUVr correlated with lower glutamate/myo-inositol (r = -.3, P = .04). CONCLUSIONS: The advanced sLASER with FAST(EST)MAP shimming is a promising protocol for identifying glutamate alterations. Advanced 1 H-MRS protocols may add to the understanding of early Alzheimer's disease pathophysiology through detection of glutamate concentration in posterior cingulate gyri of individuals with amnestic mild cognitive impairment.
Authors: Catherine M L Foy; Eileen M Daly; Amanda Glover; Ruth O'Gorman; Andrew Simmons; Declan G M Murphy; Simon Lovestone Journal: Brain Topogr Date: 2011-02-05 Impact factor: 3.020
Authors: Georg Oeltzschner; S Andrea Wijtenburg; Mark Mikkelsen; Richard A E Edden; Peter B Barker; Jin Hui Joo; Jeannie-Marie S Leoutsakos; Laura M Rowland; Clifford I Workman; Gwenn S Smith Journal: Neurobiol Aging Date: 2018-09-27 Impact factor: 4.673
Authors: Reena V Kartha; James Joers; Marcia R Terluk; Abigail Travis; Kyle Rudser; Paul J Tuite; Neal J Weinreb; Jeanine R Jarnes; James C Cloyd; Gülin Öz Journal: J Inherit Metab Dis Date: 2019-12-17 Impact factor: 4.982
Authors: Young Woo Park; Dinesh K Deelchand; James M Joers; Brian Hanna; Adam Berrington; Joseph S Gillen; Kejal Kantarci; Brian J Soher; Peter B Barker; HyunWook Park; Gülin Öz; Christophe Lenglet Journal: Magn Reson Med Date: 2018-04-06 Impact factor: 4.668
Authors: Gülin Öz; Dinesh K Deelchand; Jannie P Wijnen; Vladimír Mlynárik; Lijing Xin; Ralf Mekle; Ralph Noeske; Tom W J Scheenen; Ivan Tkáč Journal: NMR Biomed Date: 2020-01-10 Impact factor: 4.044
Authors: Firat Kara; James M Joers; Dinesh K Deelchand; Young Woo Park; Scott A Przybelski; Timothy G Lesnick; Matthew L Senjem; Burcu Zeydan; David S Knopman; Val J Lowe; Prashanthi Vemuri; Michelle M Mielke; Mary M Machulda; Clifford R Jack; Ronald C Petersen; Gülin Öz; Kejal Kantarci Journal: Neurobiol Aging Date: 2022-01-05 Impact factor: 4.673
Authors: Tao Song; Xiaopeng Song; Chenyawen Zhu; Regan Patrick; Miranda Skurla; Isabella Santangelo; Morgan Green; David Harper; Boyu Ren; Brent P Forester; Dost Öngür; Fei Du Journal: Ageing Res Rev Date: 2021-10-29 Impact factor: 10.895
Authors: L L de Godoy; A Studart-Neto; M Wylezinska-Arridge; M H Tsunemi; N C Moraes; M S Yassuda; A M Coutinho; C A Buchpiguel; R Nitrini; S Bisdas; C da Costa Leite Journal: AJNR Am J Neuroradiol Date: 2021-08-26 Impact factor: 4.966
Authors: David R Roalf; Valerie J Sydnor; Madison Woods; David A Wolk; J Cobb Scott; Ravinder Reddy; Paul J Moberg Journal: Neurobiol Aging Date: 2020-07-21 Impact factor: 4.673
Authors: Qin Chen; Bradley F Boeve; Nirubol Tosakulwong; Timothy Lesnick; Danielle Brushaber; Christina Dheel; Julie Fields; Leah Forsberg; Ralitza Gavrilova; Debra Gearhart; Dana Haley; Jeffrey L Gunter; Jonathan Graff-Radford; David Jones; David Knopman; Neill Graff-Radford; Ruth Kraft; Maria Lapid; Rosa Rademakers; Jeremy Syrjanen; Zbigniew K Wszolek; Howie Rosen; Adam L Boxer; Kejal Kantarci Journal: Neurology Date: 2019-07-17 Impact factor: 11.800